These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 23421589

  • 1. Rational discovery of dengue type 2 non-competitive inhibitors.
    Heh CH, Othman R, Buckle MJ, Sharifuddin Y, Yusof R, Rahman NA.
    Chem Biol Drug Des; 2013 Jul; 82(1):1-11. PubMed ID: 23421589
    [Abstract] [Full Text] [Related]

  • 2. Identification of novel thiadiazoloacrylamide analogues as inhibitors of dengue-2 virus NS2B/NS3 protease.
    Liu H, Wu R, Sun Y, Ye Y, Chen J, Luo X, Shen X, Liu H.
    Bioorg Med Chem; 2014 Nov 15; 22(22):6344-52. PubMed ID: 25438757
    [Abstract] [Full Text] [Related]

  • 3. Discovery and SAR studies of methionine-proline anilides as dengue virus NS2B-NS3 protease inhibitors.
    Zhou GC, Weng Z, Shao X, Liu F, Nie X, Liu J, Wang D, Wang C, Guo K.
    Bioorg Med Chem Lett; 2013 Dec 15; 23(24):6549-54. PubMed ID: 24268549
    [Abstract] [Full Text] [Related]

  • 4. Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction.
    Wichapong K, Pianwanit S, Sippl W, Kokpol S.
    J Mol Recognit; 2010 Dec 15; 23(3):283-300. PubMed ID: 19693793
    [Abstract] [Full Text] [Related]

  • 5. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.
    Lescar J, Luo D, Xu T, Sampath A, Lim SP, Canard B, Vasudevan SG.
    Antiviral Res; 2008 Nov 15; 80(2):94-101. PubMed ID: 18674567
    [Abstract] [Full Text] [Related]

  • 6. Structure-guided Discovery of a Novel Non-peptide Inhibitor of Dengue Virus NS2B-NS3 Protease.
    Li L, Basavannacharya C, Chan KW, Shang L, Vasudevan SG, Yin Z.
    Chem Biol Drug Des; 2015 Sep 15; 86(3):255-64. PubMed ID: 25533891
    [Abstract] [Full Text] [Related]

  • 7. Binding of low molecular weight inhibitors promotes large conformational changes in the dengue virus NS2B-NS3 protease: fold analysis by pseudocontact shifts.
    de la Cruz L, Nguyen TH, Ozawa K, Shin J, Graham B, Huber T, Otting G.
    J Am Chem Soc; 2011 Nov 30; 133(47):19205-15. PubMed ID: 22007671
    [Abstract] [Full Text] [Related]

  • 8. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
    Dwivedi VD, Tripathi IP, Mishra SK.
    J Vector Borne Dis; 2016 Nov 30; 53(2):156-61. PubMed ID: 27353586
    [Abstract] [Full Text] [Related]

  • 9. Allosteric pocket of the dengue virus (serotype 2) NS2B/NS3 protease: In silico ligand screening and molecular dynamics studies of inhibition.
    Mukhametov A, Newhouse EI, Aziz NA, Saito JA, Alam M.
    J Mol Graph Model; 2014 Jul 30; 52():103-13. PubMed ID: 25023665
    [Abstract] [Full Text] [Related]

  • 10. Construction of dengue virus protease expression plasmid and in vitro protease assay for screening antiviral inhibitors.
    Lai H, Teramoto T, Padmanabhan R.
    Methods Mol Biol; 2014 Jul 30; 1138():345-60. PubMed ID: 24696347
    [Abstract] [Full Text] [Related]

  • 11. Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal.
    Viswanathan U, Tomlinson SM, Fonner JM, Mock SA, Watowich SJ.
    J Chem Inf Model; 2014 Oct 27; 54(10):2816-25. PubMed ID: 25263519
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Allosteric inhibition of the NS2B-NS3 protease from dengue virus.
    Yildiz M, Ghosh S, Bell JA, Sherman W, Hardy JA.
    ACS Chem Biol; 2013 Dec 20; 8(12):2744-52. PubMed ID: 24164286
    [Abstract] [Full Text] [Related]

  • 16. Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation.
    Niyomrattanakit P, Winoyanuwattikun P, Chanprapaph S, Angsuthanasombat C, Panyim S, Katzenmeier G.
    J Virol; 2004 Dec 20; 78(24):13708-16. PubMed ID: 15564480
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the West Nile virus protease substrate specificity and inhibitors.
    Mueller NH, Yon C, Ganesh VK, Padmanabhan R.
    Int J Biochem Cell Biol; 2007 Dec 20; 39(3):606-14. PubMed ID: 17188926
    [Abstract] [Full Text] [Related]

  • 18. Identification of potential hit compounds for Dengue virus NS2B/NS3 protease inhibitors by combining virtual screening and binding free energy calculations.
    Wichapong K, Nueangaudom A, Pianwanit S, Sippl W, Kokpol S.
    Trop Biomed; 2013 Sep 20; 30(3):388-408. PubMed ID: 24189670
    [Abstract] [Full Text] [Related]

  • 19. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
    Kouretova J, Hammamy MZ, Epp A, Hardes K, Kallis S, Zhang L, Hilgenfeld R, Bartenschlager R, Steinmetzer T.
    J Enzyme Inhib Med Chem; 2017 Dec 20; 32(1):712-721. PubMed ID: 28385094
    [Abstract] [Full Text] [Related]

  • 20. Identification of novel and potential inhibitors against the dengue virus NS2B/NS3 protease using virtual screening and biomolecular simulations.
    Nasir A, Samad A, Ajmal A, Li P, Islam M, Ullah S, Shah M, Bai Q.
    Int J Biol Macromol; 2024 Jun 20; 272(Pt 1):132855. PubMed ID: 38834129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.